News

X-ZELL technology suite upgrade underway

Singapore, October 2018 – Cancer detection specialist, X-ZELL Inc., has announced a new version of the company’s world-unique Cryoimmunostaining™ suite. Whilst keeping details close to his chest, X-ZELL’s Head of Engineering & QA, Bart Van der Voort, revealed that...

More Bangkok hospitals embrace ground-breaking new liquid biopsy

Bangkok, October 2018 – Prostate cancer patients in Bangkok now have more access to state-of-the-art cancer detection technology than ever before. After debuting at Bangkok’s Chularat 9 Hospital at the end of 2017, X-ZELL Prostate™ – the first liquid biopsy based on...

X-ZELL among 16 most innovative health-tech start-ups in Asia

Singapore, September 2018 – Galen Growth, a Singapore-based analytics and advisory firm specialising in cutting-edge healthcare technology, has named X-ZELL Inc. as one of the 16 most innovative health technology start-ups in Asia. Selected to feature in the 2018...

X-ZELL technology featured in British urology journal

Oxford, August 2018 – X-ZELL Inc. CEO, Dr Sebastian Bhakdi, has published new research into the utility of tumour-derived Circulating Endothelial Cells (tCEC) for the detection of early-stage prostate cancer. His latest abstract – titled Tumor‐Derived Circulating...

X-ZELL launches global Cryoimmunostaining™ technology trial

Bangkok, July 2018 – After successfully completing a series of clinical trials across Southeast Asia, rare cell detection specialist X-ZELL Inc. is now making the company’s patented Cryoimmunostaining™ technology available to research organisations around the globe....

X-ZELL CEO to present at APCC 2018

Brisbane, July 2018 – X-ZELL Inc. CEO, Dr Sebastian Bhakdi, will use the upcoming Asia-Pacific Prostate Cancer Conference (APCC) in Brisbane next month as a platform to reveal “exciting new insights” into early prostate cancer detection. According to Dr Bhakdi, his...

NUH Singapore and X-ZELL agree on landmark cancer detection study

Singapore, June 2018 – The Department of Urology at Singapore’s National University Hospital and X-ZELL Inc. have signed a Letter of Intent (LOI) to jointly conduct a prospective, blinded study evaluating the utility of X-ZELL Prostate™ for early prostate cancer...

X-ZELL CEO reveals ground-breaking new microscopy method

Basel, June 2018 – Dr Sebastian Bhakdi, CEO of cancer detection start-up X-ZELL Inc., has outlined a ground-breaking new microscopy technique in the June edition of Methods & Protocols. In a bid to make the benefits of immunofluorescence staining more accessible in...

X-ZELL CEO reveals path to success in burgeoning biotech market

Singapore, May 2018 – X-ZELL CEO, Dr Sebastian Bhakdi, used his guest speaking spot at the 2018 HealthInvestor Asia Summit today to reflect on the opportunities and challenges biotechnology start-ups face in Asia and why so many of them fail to go all the way from...

X-ZELL launches new biotech blog

Singapore, May 2018 – X-ZELL Inc., one of Asia’s first Silicon Valley-backed biotech start-ups, has used today’s HealthInvestor Asia Summit in Singapore as a launch pad for a new biotech industry blog. According to X-ZELL CEO, Dr Sebastian Bhakdi, the blog will allow...

Get in Touch

Use the form below to contact us for more information.

X-ZELL

FIGHTING CANCER,
ONE CELL AT A TIME.

© 2017 X-ZELL INC

Find Us

XZELL HQ